Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

Now watching

Next video starts in : 7 Play

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted
Replay video
Up next

HP Details Company Split; Gap Struggles to Rekindle Brand Interest

Unlock your personal NFL Now stream by signing in to NFL.com

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

by TheStreet 0:59 mins

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

by TheStreet 0:59 mins

Analysts at Jefferies are estimating that pharmaceutical company AbbVie could find itself a deal if it sweetens its $46 billion takeover offer for London-listed rival Shire. Jefferies analysts estimate that AbbVie could improve its offer to 55 pounds a share, or $55 billion. That's up from its most recent cash-and-shares offer of just over 46 pounds, which was rejected. Shire has argued that AbbVie's offer undervalues its business. Since the offer, Shire is giving long-range forecasts for its drugs, predicting that its $4.9 billion in sales in 2013 may double to $10 billion by 2020, helped by its successful ADHD treatment.

TheStreet

Personal Finance

  1. 2:22

    How this woman tracked down her identity thief

  2. 2:23

    3 strategies that can help simplify your life

  3. 2:14

    Would you give your dog your kidney?

  4. 2:14

    5 unique summer jobs that pay great

  5. 1:03

    Money Minute: What employers are really looking for

  6. 2:31

    CEO cashes out to become a farmer

Market Movers